(Q53067121)

11 May 2018

title

GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells. (English)

1 reference

11 May 2018

author

Ana Claudia Zenclussen

6

1 reference

11 May 2018

author name string

Christine Weißenborn

1

1 reference

11 May 2018

Tanja Ignatov

2

1 reference

11 May 2018

Angela Poehlmann

3

1 reference

11 May 2018

Anja K Wege

4

1 reference

11 May 2018

Serban D Costa

5

1 reference

11 May 2018

Atanas Ignatov

7

1 reference

11 May 2018

publication date

11 February 2014

1 reference

11 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

11 May 2018

volume

140

1 reference

11 May 2018

issue

4

1 reference

11 May 2018

page(s)

663-671

1 reference

11 May 2018

Progestin and G protein-coupled receptor 30 inhibit mitogen-activated protein kinase activity in MCF-7 breast cancer cells

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Optimizing high-resolution melting analysis for the detection of mutations of GPR30/GPER-1 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Virtual and biomolecular screening converge on a selective agonist for GPR30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Role of cyclin B1/Cdc2 up-regulation in the development of mitotic prometaphase arrest in human breast cancer cells treated with nocodazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Insulin-like growth factor-I regulates GPER expression and function in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

In vivo effects of a GPR30 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

G-protein-coupled receptors and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Histone H3 phosphorylation and cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Sphingosine-1-phosphate is a high-affinity ligand for the G protein-coupled receptor GPR6 from mouse and induces intracellular Ca2+ release by activating the sphingosine-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

APC promoter hypermethylation is an early event in endometrial tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

GPER-1 acts as a tumor suppressor in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

GPER-1 expression decreases during breast cancer tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

MethPrimer: designing primers for methylation PCRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Effects of a combined treatment with GPR30 agonist G-1 and herceptin on growth and gene expression of human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Tumor suppressor genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Heregulin-β1-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2/ErbB3-MAPK/ERK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

GPR30 predicts poor survival for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Epigenetic-based therapies in cancer: progress to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

An essential role for p73 in regulating mitotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

The correlation between GPR30 and clinicopathologic variables in breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1598-2

The interactions between GPR30 and the major biomarkers in infiltrating ductal carcinoma of the breast in an Asian population

21 January 2018

1 reference

12 December 2020

The putative G-protein coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian and breast cancer cells in a GPER-independent manner.

1 reference

12 December 2020

P16 alterations increase the metastatic potential of endometrial carcinoma

1 reference

12 December 2020

Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression

1 reference

12 December 2020

Expression of CD133, PAX2, ESA, and GPR30 in invasive ductal breast carcinomas.

1 reference

12 December 2020

The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle

1 reference

12 December 2020

A gene hypermethylation profile of human cancer

1 reference

12 December 2020

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

1 reference

12 December 2020

Regulation of HRG-β1-induced proliferation, migration and invasion of MCF-7 cells by upregulation of GPR30 expression

1 reference

12 December 2020

GPR30: a novel indicator of poor survival for endometrial carcinoma

1 reference

12 December 2020

The Cell Surface Estrogen Receptor, G Protein- Coupled Receptor 30 (GPR30), is Markedly Down Regulated During Breast Tumorigenesis

1 reference

12 December 2020

10.1007/S00432-014-1598-2

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018